Third, TB-500 reduces inflammation and promotes new blood vessel formation
Liraglutide Liraglutide is an FDA-approved GLP-1 weight loss injection that helps control appetite, reduce cravings, and support lasting weight loss
This choice reflects cost and stability considerations rather than optimal bioavailability
Quick match-up (goals pick): General tissue regeneration TB-500 Localized tendon/ligament repair BPC-157 Gut-lining support/protection BPC-157 Vascular remodeling & soft-tissue recovery TB-500 Systemic inflammation modulation* TB-500 (*BPC-157 also shows anti-inflammatory actions in preclinical data) Neuroregeneration/braingut axis support BPC-157 Potential Side Effects and Safety Considerations For TB-500 vs BPC-157 Although both TB-500 and BPC-157 are generally regarded as well-tolerated in preclinical studies , users should be aware of potential side effects
[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Du P, Ye Y, Seitz PK, Bi LG, Li H, Wang C, et al